2016
DOI: 10.1016/j.ica.2015.10.040
|View full text |Cite
|
Sign up to set email alerts
|

New non-aggregating bivalent cis-ML2 (M = Pd, Pt; L = pivaloylcyanoxime)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
14
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 41 publications
1
14
0
Order By: Relevance
“…All the crystals were placed on plastic MiTeGen holders attached to the copper-pin positioned on the goniometer head of the Bruker APEX-2 diffractometer, equipped with a SMART CCD area detector. The intensity data were collected at room and low temperatures in order to examine the possibility for temperature-dependent polymorphism that has been recently observed in other Pt-cyanoximates, 50 but was not observed in presented in this work complexes. Only low temperature data is presented in this work.…”
Section: Methodsmentioning
confidence: 89%
See 1 more Smart Citation
“…All the crystals were placed on plastic MiTeGen holders attached to the copper-pin positioned on the goniometer head of the Bruker APEX-2 diffractometer, equipped with a SMART CCD area detector. The intensity data were collected at room and low temperatures in order to examine the possibility for temperature-dependent polymorphism that has been recently observed in other Pt-cyanoximates, 50 but was not observed in presented in this work complexes. Only low temperature data is presented in this work.…”
Section: Methodsmentioning
confidence: 89%
“…It should be mentioned that the structure of Pt(PiPCO) 2 was determined earlier at 293 K, but we re-grew suitable single crystals and re-determined the structure more accurately at low temperature (100 K) because of the recently observed polymorphism in other Pt-cyanoximates. 50 …”
Section: Resultsmentioning
confidence: 99%
“…The preparation of the HPiCO was carried out according to previously published procedure, , while the reactions in the cyanoxime–Zn system are presented in Scheme and in a set of equations below. For the preparation of Zn­(II) complex, 0.300 g (1.95 mM) of white powdery HPiCO was placed in a beaker containing 5 mL of deionized water, to which 1.95 mL of 1 M KOH solution was added at once.…”
Section: Experimental Partmentioning
confidence: 99%
“…In addition, the use of nanotechnology-based drug delivery system is an emerging area of interest for increased payloads, biocompatibility, and targeted delivery of chemotherapeutic drugs, resulting in minimal side effects. Recent studies indicate the huge potential of various nanoparticles as drug carriers in cancer therapy, including targeted drug delivery, diagnosis, imaging, and treatment [38][39][40][41][42][43]. Among others, cerium oxide nanoparticles (NC) has received considerable attention due to its excellent catalytic and antioxidant properties with different cell systems.…”
Section: Introductionmentioning
confidence: 99%